These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1615221)

  • 1. Direct antitumor effects of LH-RH analogs.
    Foekens JA; Klijn JG
    Recent Results Cancer Res; 1992; 124():7-17. PubMed ID: 1615221
    [No Abstract]   [Full Text] [Related]  

  • 2. Gonadotrophin hormone releasing analogues open new doors in cancer treatment.
    Waxman J
    Br Med J (Clin Res Ed); 1987 Oct; 295(6606):1084-5. PubMed ID: 2961401
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypothalamic hormones and cancer.
    Schally AV; Comaru-Schally AM; Nagy A; Kovacs M; Szepeshazi K; Plonowski A; Varga JL; Halmos G
    Front Neuroendocrinol; 2001 Oct; 22(4):248-91. PubMed ID: 11587553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential use of analogs of luteinizing hormone-releasing hormones in the treatment of hormone-sensitive neoplasms.
    Schally AV; Redding TW; Comaru-Schally AM
    Cancer Treat Rep; 1984 Jan; 68(1):281-9. PubMed ID: 6362868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation and change in subcellular distribution of receptors for luteinizing hormone-releasing hormone in OV-1063 human epithelial ovarian cancers during therapy with LH-RH antagonist Cetrorelix.
    Halmos G; Schally AV; Kahan Z
    Int J Oncol; 2000 Aug; 17(2):367-73. PubMed ID: 10891548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the management of metastatic prostate cancer with LH-RH analogs.
    Blom JH; Schröder FH
    Recent Results Cancer Res; 1992; 124():33-41. PubMed ID: 1615217
    [No Abstract]   [Full Text] [Related]  

  • 7. Antitumor effects of analogs of hypothalamic hormones in endocrine-dependent cancers.
    Schally AV; Comaru-Schally AM; Redding TW
    Proc Soc Exp Biol Med; 1984 Mar; 175(3):259-81. PubMed ID: 6141569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [LHRH analogs--a new treatment in hormone-dependent tumors].
    Wilking N; Rutqvist LE; Theve T
    Lakartidningen; 1988 Feb; 85(8):620-3. PubMed ID: 3280927
    [No Abstract]   [Full Text] [Related]  

  • 9. [History of clinical studies on hypothalamic hormone analogs in Mexico].
    Schally AV; González Bárcena D
    Gac Med Mex; 2006; 142(4):315-25. PubMed ID: 17022307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of LH_RH analogs in the treatment of cancer of the prostate. A report of the conference organized by ICI_Pharma Laboratories (part 1)].
    Prog Urol; 1991 Feb; 1(1):165-8. PubMed ID: 1364642
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostatic carcinoma with lung metastases in a former bagasse worker; LH-RH analogs as an alternative therapy.
    Comaru-Schally AM; Kushner DS
    Am J Med Sci; 1988 Nov; 296(5):348-53. PubMed ID: 2973752
    [No Abstract]   [Full Text] [Related]  

  • 12. Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
    Schally AV; Redding TW
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7275-9. PubMed ID: 2890164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [LH-RH analogs in mammary carcinoma: experimental aspects].
    Scambia G; Benedetti Panici P; De Vincenzo R; Isola G; Mancuso S
    Drugs Exp Clin Res; 1990; 16 Suppl():39-46. PubMed ID: 2081450
    [No Abstract]   [Full Text] [Related]  

  • 14. Luteinizing hormone-releasing hormone (LH-RH) analogs in treatment of prostatic cancer. Clinical perspective.
    Smith JA
    Urology; 1986 Jan; 27(1 Suppl):9-15. PubMed ID: 3079936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LH-RH agonists in the treatment of ovarian cancer.
    Emons G; Ortmann O; Pahwa GS; Oberheuser F; Schulz KD
    Recent Results Cancer Res; 1992; 124():55-68. PubMed ID: 1615219
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of experimental ovarian carcinoma with monthly injection of the agonist D-Trp-6-LH-RH: a preliminary report.
    Pour PM; Redding TW; Paz-Bouza JI; Schally AV
    Cancer Lett; 1988 Jul; 41(1):105-10. PubMed ID: 2968836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth inhibition of human ovarian cancers by cytotoxic analogues of luteinizing hormone-releasing hormone.
    Miyazaki M; Nagy A; Schally AV; Lamharzi N; Halmos G; Szepeshazi K; Groot K; Armatis P
    J Natl Cancer Inst; 1997 Dec; 89(23):1803-9. PubMed ID: 9392622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonists of bombesin/gastrin-releasing peptides as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
    Pinski J; Halmos G; Szepeshazi K; Schally AV
    Cancer; 1993 Dec; 72(11):3263-70. PubMed ID: 8242552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [LH-RH analogue].
    Ogawa Y; Igarashi A
    Nihon Rinsho; 2011 Jun; 69 Suppl 5():469-72. PubMed ID: 22208025
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prostatic cancer. Treatment with LH-RH analogs].
    Ogreid P
    Tidsskr Nor Laegeforen; 1986 Dec; 106(34-36):2968-70. PubMed ID: 3544333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.